CIPROFLOXACIN AND STREPTOMYCIN AS DRUGS OF CHOICE IN TREATMENT OF SURGICAL SITE INFECTIONS IN MAIDUGURI
| Autor: | S T Balogun, OA Sodipo, L. M. Paul, Akanmu Ao, Anonde Ce |
|---|---|
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Kanem Journal Medical Sciences. 15:13-18 |
| ISSN: | 2714-2426 2006-4772 |
| DOI: | 10.36020/kjms.2021.1501.002 |
| Popis: | Background: Surgical site infections (SSIs) are medical events that have direct unintended consequences on patients. They often result in increased hospitalization and a greater number of diagnostic and therapeutic procedures. In Maiduguri, they are a major source of post-operative illness among hospitalized patients. Hence, it is important to determine the scope of bacteria involvement and identify suitable antibacterial agents for effective treatment. Objectives: The study was designed to determine the prevalence of SSIs in patients with surgical wounds, determine the antibiogram of the bacteria involved and drug of choice in the treatment of SSIs. Methodology: The study design was cross-sectional using the qualitative approach. Patients with surgically created wounds infected (>30 days post-surgery) were enrolled between April and May 2018 at UMTH following informed consent. Swab samples were aseptically collected from the patients. The isolation and identification of bacterial isolates were done by cultural, microscopic and biochemical characterization. The antibiogram of the bacterial isolates was determined using disc diffusion method. Appropriate statistical tools were used. Results: A total of 70 patients with surgically created wounds were enrolled. The prevalence of SSIs in patients with surgically created wounds was 95.7% (67/70). Three bacterial species were identified with S. aureus accounting for the highest proportion of 68.7% (46/67) while Klebsiella spp was (19.4 %, 13/67) and E. coli was (11.9 %, 8/67) [p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|